Consolidative breast radiotherapy and prophylactic high-dose methotrexate are important first-line treatments for primary breast diffuse large B-cell lymphoma patients treated with R-CHOP-like regimens
Huawei Weng(Sun Yat-sen University), Tongyu Lin(University of Electronic Science and Technology of China), Zegeng Chen(Harbin Institute of Technology), Mengdi Wan(University of Electronic Science and Technology of China), Liqun Zou(Sichuan University), Bo Zhu(Army Medical University), Hui Zhou(Hunan Cancer Hospital), Huangming Hong(Sun Yat-sen University), Xudong Li(University of Electronic Science and Technology of China), Zhao Wang(Capital Medical University), Yuyi Yao(Sun Yat-sen University), Yao Liu(Chongqing University), Xiaoqian Li(University of Electronic Science and Technology of China), Fei Pan(Anhui University of Traditional Chinese Medicine), Wei Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yongchang Chen(Jiangsu University), He Huang(Sun Yat-sen University), Xiaojie Fang(Sun Yat-sen University), Xianling Liu(Central South University), Le Yu(Xiamen University), Hongqiang Guo(Zhengzhou University), Zhihui Zhang(Army Medical University), Prem Raj Shrestha(Sun Yat-sen University)
Cited by 0
Related Papers
Genome-scale analysis of aberrant DNA methylation in colorectal cancer
|Genome Research|2011|610
PARP inhibitor resistance: the underlying mechanisms and clinical implications
|Molecular Cancer|2020|548
Recent advances in CAR-T cell engineering
|Journal of Hematology & Oncology|2020|403
Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo
|Experimental and Molecular Pathology|2005|388
Mesenchymal Stern Cells from Adult Human Bone Marrow Differentiate into a Cardiomyocyte Phenotype In Vitro
|Experimental Biology and Medicine|2004|372